ResMed Sleep And Breathing Health — Cost of Sales decreased by 0.6% to $479.19M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.6%, from $466.98M to $479.19M. Over 2 years (FY 2023 to FY 2025), Sleep And Breathing Health — Cost of Sales shows an upward trend with a 5.7% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or supply chain inefficiencies, while a decrease indicates improved manufacturing margins.
Represents the direct costs attributable to the production and delivery of goods and services within the Sleep and Breat...
Standard cost of goods sold (COGS) metric found in all manufacturing and medical device companies.
rmd_segment_sleep_and_breathing_health_cost_of_sales| Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $414.76M | $414.76M | $414.76M | $414.76M | $445.51M | $445.51M | $445.51M | $445.51M | $449.45M | $467.97M | $466.98M | $468.17M | $453.19M | $482.25M | $479.19M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +7.4% | +0.0% | +0.0% | +0.0% | +0.9% | +4.1% | -0.2% | +0.3% | -3.2% | +6.4% | -0.6% |
| YoY Change | — | — | — | — | +7.4% | +7.4% | +7.4% | +7.4% | +0.9% | +5.0% | +4.8% | +5.1% | +0.8% | +3.1% | +2.6% |